Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onur Turan

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
International Journal of Chronic Obstructive Pulmonary Disease|April 10, 2024
Can the ADO Index Be Used as a Predictor of Mortality from COVID-19 in Patients with COPD?Esra Ertan Yazar, Gulsah Gunluoglu, Burcu Arpinar Yigitbas, et al.
Thoracic Research and Practice|August 8, 2024
Factors Associated with Increasing Costs in Severe Chronic Obstructive Pulmonary Disease Exacerbation: Turkish Thoracic Society Chronic Obstructive Pulmonary Disease AssemblyAyşe Baha, Nurdan Köktürk, Caner Baysan, et al.
The American Journal of the Medical Sciences|July 11, 2025
COPET study findings regarding the clinical relevance of biomass exposure as an etiotype in COPDEsra Ertan Yazar, Nilgün Demirci, Burcu Arpınar Yiğitbaş, et al.
Turkish Journal of Medical Sciences|November 3, 2022
Chronic obstructive pulmonary disease phenotypes in Turkey: the COPET study-a national, multicenter cross-sectional observational studyEsra Ertan Yazar, Burcu Arpınar Yiğitbaş, Can Öztürk, et al.
Expert Review of Respiratory Medicine|July 15, 2022
Characteristics of our hypoxemic COVID-19 pneumonia patients receiving corticosteroids and mortality-associated factorsAysun Şengül, Pınar Mutlu, Özer Özdemir, et al.
Tuberkuloz Ve Toraks|January 8, 2013
Evaluation of inhaler technique and patient satisfaction with fixed-combination budesonide/formoterol dry-powder inhaler in chronic obstructive pulmonary disease (COPD): data on real-life clinical practice in TurkeyCan Öztürk, Akın Kaya, Cahit Bilgin, et al.
Medicine|November 29, 2024
Readmission rates within the first 30 and 90 days after severe COPD exacerbations (RACE study)Oya Baydar Toprak, Mehmet Polatli, Ayşe Baha, et al.
BMC Pulmonary Medicine|November 28, 2024
Risk factors for prolonged hospitalization as a marker for difficult-to-manage exacerbations of chronic obstructive lung disease (COPD): the DiMECO StudyDorina Esendağlı, Nurdan Köktürk, Ayşe Baha, et al.
The Clinical Respiratory Journal|April 4, 2019
Carotid intima-media thickness in chronic obstructive pulmonary disease and survival: A multicenter prospective studyGazi Gulbas, Onur Turan, Nurhan Sarioglu, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
International Journal of Chronic Obstructive Pulmonary Disease|April 10, 2024
Can the ADO Index Be Used as a Predictor of Mortality from COVID-19 in Patients with COPD?Esra Ertan Yazar, Gulsah Gunluoglu, Burcu Arpinar Yigitbas, et al.
Thoracic Research and Practice|August 8, 2024
Factors Associated with Increasing Costs in Severe Chronic Obstructive Pulmonary Disease Exacerbation: Turkish Thoracic Society Chronic Obstructive Pulmonary Disease AssemblyAyşe Baha, Nurdan Köktürk, Caner Baysan, et al.
The American Journal of the Medical Sciences|July 11, 2025
COPET study findings regarding the clinical relevance of biomass exposure as an etiotype in COPDEsra Ertan Yazar, Nilgün Demirci, Burcu Arpınar Yiğitbaş, et al.
Turkish Journal of Medical Sciences|November 3, 2022
Chronic obstructive pulmonary disease phenotypes in Turkey: the COPET study-a national, multicenter cross-sectional observational studyEsra Ertan Yazar, Burcu Arpınar Yiğitbaş, Can Öztürk, et al.
Expert Review of Respiratory Medicine|July 15, 2022
Characteristics of our hypoxemic COVID-19 pneumonia patients receiving corticosteroids and mortality-associated factorsAysun Şengül, Pınar Mutlu, Özer Özdemir, et al.
Tuberkuloz Ve Toraks|January 8, 2013
Evaluation of inhaler technique and patient satisfaction with fixed-combination budesonide/formoterol dry-powder inhaler in chronic obstructive pulmonary disease (COPD): data on real-life clinical practice in TurkeyCan Öztürk, Akın Kaya, Cahit Bilgin, et al.
Medicine|November 29, 2024
Readmission rates within the first 30 and 90 days after severe COPD exacerbations (RACE study)Oya Baydar Toprak, Mehmet Polatli, Ayşe Baha, et al.
BMC Pulmonary Medicine|November 28, 2024
Risk factors for prolonged hospitalization as a marker for difficult-to-manage exacerbations of chronic obstructive lung disease (COPD): the DiMECO StudyDorina Esendağlı, Nurdan Köktürk, Ayşe Baha, et al.
The Clinical Respiratory Journal|April 4, 2019
Carotid intima-media thickness in chronic obstructive pulmonary disease and survival: A multicenter prospective studyGazi Gulbas, Onur Turan, Nurhan Sarioglu, et al.
Pageof 4